Literature DB >> 8781025

Secretion of organic anions by hepatocytes: involvement of homologues of the multidrug resistance protein.

M Müller1, H Roelofsen, P L Jansen.   

Abstract

The canalicular multispecific organic anion transporter (cMOAT) is one of at least four ATP-dependent transport systems identified so far in the canalicular membrane domain. Using mutant rat strains that lack organic anion secretion, the substrate specificity of cMOAT has been characterized. cMOAT appears to be responsible for the elimination of amphipathic anionic conjugates formed by phase II conjugation. Very recently it has been shown that the hepatocyte-specific homologue (MRP2) of the multidrug resistance protein (MRP1) functions as cMOAT in the canalicular membrane, whereas MRP1 is present in the lateral membrane only at very low levels in quiescent cells. The defective excretion of organic anions in TR- rate livers is caused by the total absence of mrp2 due to a deletion of one nucleotide in the mrp2 gene. In conclusion, the liver-specific mrp2/MRP2, a new member of the ATP-binding cassette superfamily, appears to function as cMOAT in the hepatobiliary secretion of organic anions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781025     DOI: 10.1055/s-2007-1007233

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  14 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Alteration of canalicular transporters in a mouse model of total parenteral nutrition.

Authors:  Yuko Tazuke; Daniel H Teitelbaum
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

3.  The gene encoding the multispecific organic anion transporter (Cmoat) of the hepatocyte canalicular membrane maps to mouse chromosome 19.

Authors:  F Lammert; D E Cohen; B Paigen; M C Carey; D R Beier
Journal:  Mamm Genome       Date:  1998-01       Impact factor: 2.957

Review 4.  Cholangiocyte anion exchange and biliary bicarbonate excretion.

Authors:  Jesús-M Banales; Jesus Prieto; Juan-F Medina
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

5.  A fluorometric screening assay for drug efflux transporter activity in the blood-brain barrier.

Authors:  Corbin J Bachmeier; Donald W Miller
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

6.  ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.

Authors:  J Renes; E G de Vries; E F Nienhuis; P L Jansen; M Müller
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

7.  Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal.

Authors:  J Renes; E E de Vries; G J Hooiveld; I Krikken; P L Jansen; M Müller
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

8.  Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.

Authors:  V D Makhey; A Guo; D A Norris; P Hu; J Yan; P J Sinko
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

9.  Characterization of an ankyrin repeat-containing Shank2 isoform (Shank2E) in liver epithelial cells.

Authors:  Ryan R McWilliams; Elizabeth Gidey; Laura Fouassier; Scott A Weed; R Brian Doctor
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

10.  Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups.

Authors:  David T Szabo; Vicki M Richardson; David G Ross; Janet J Diliberto; Prasada R S Kodavanti; Linda S Birnbaum
Journal:  Toxicol Sci       Date:  2008-10-31       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.